All companies
Visit website
EO2 CONCEPTS
OperatingElectrochemical Oxygen Concepts, Inc.
Healthcare · Technology · Founded 2007
Oxygen-enhanced technology for advanced wound healing and skin support
Post-money valuation ⓘ
$79.3M
As of Aug 2023 · from EO2 Concepts Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$742,359
Across 1 round since 2022
Latest share price
$1.59
EO2 Concepts Preferred Stock 1 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$1.5M
−$2.7M
2020
$2.1M
−$2.5M
2021
$3.8M
−$2.7M
2022
$6.4M
−$3.7M
2023
$5.7M
−$4.2M
2024
$4.1M
−$722K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$1,450,379
$2,130,220
$3,761,573
$6,401,908
$5,723,605
$4,143,000
Cost of goods sold
$346,961
$640,373
$778,225
$691,453
$729,062
$86,222
Gross margin
76%
70%
79%
89%
87%
98%
Net income
-$2,692,694
-$2,517,980
-$2,738,366
-$3,670,123
-$4,189,401
-$722,240
Taxes paid
$0
$0
$0
$0
$0
$3,984
Balance sheet
Cash
$219,385
$72,823
$606,116
$221,966
$233,493
$46,530
Accounts receivable
$489,583
$1,024,322
$1,006,778
$2,768,886
$0
$3,366,808
Total assets
$1,477,228
$1,719,463
$3,568,756
$5,474,111
$22,502,217
$3,923,424
Short-term debt
$900,240
$1,386,548
$210,819
$2,443,072
$2,492,313
$2,492,313
Long-term debt
$2,707,598
$4,446,595
$7,799,257
$12,200,041
$0
$21,153,046
Total liabilities
$3,607,838
$5,833,143
$8,010,076
$14,643,113
$2,492,313
$23,645,359
Other
Headcount
—
22
22
19
9
22
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$79.3M
post-money
EO2 Concepts Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $742.4K / $1.2MInvestors 272Post-money $79.3M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 4 of 4 annual reports (FY2022–FY2025)
272 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 33 filings on EDGARSource: ManualCIK 0001436343Share price $1.59
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.